Market Overview

UPDATE: Auriga Raises Price Target on the Medicines Company to $25


According to Auriga, the Medicines Company (NASDAQ: MDCO) price target is raised to $25.

Auriga said that MDCO had a strong quarter due to high demand of Angiomax, with results handily beating consensus on both revenue and EPS. “We reiterate BUY and raise price target to $25.00.”

The Medicines Company closed yesterday at $22.28.

Posted-In: AurigaAnalyst Color Price Target Analyst Ratings


Related Articles (MDCO)

View Comments and Join the Discussion!

Partner Center